CITI TRENDS INC (CTRN)
US17306X1028 - Common Stock
CTRN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 125 industry peers in the Specialty Retail industry. The financial health of CTRN is average, but there are quite some concerns on its profitability. CTRN does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
CTRN had negative earnings in the past year.
In the past year CTRN has reported a negative cash flow from operations.
CTRN had positive earnings in 4 of the past 5 years.
CTRN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.30%, CTRN is in line with its industry, outperforming 44.00% of the companies in the same industry.
CTRN has a Return On Equity of -7.55%. This is comparable to the rest of the industry: CTRN outperforms 47.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.3% | ||
| ROE | -7.55% | ||
| ROIC | N/A |
ROA(3y)7.21%
ROA(5y)6.02%
ROE(3y)27.13%
ROE(5y)21.14%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 38.11%, CTRN perfoms like the industry average, outperforming 56.00% of the companies in the same industry.
CTRN's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CTRN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 38.11% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.42%
GM growth 5Y0.01%
2. Health
2.1 Basic Checks
CTRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CTRN has more shares outstanding
Compared to 5 years ago, CTRN has less shares outstanding
CTRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 2.66 indicates that CTRN is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.66, CTRN is in line with its industry, outperforming 60.00% of the companies in the same industry.
There is no outstanding debt for CTRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.66 |
ROIC/WACCN/A
WACC9.66%
2.3 Liquidity
CTRN has a Current Ratio of 1.32. This is a normal value and indicates that CTRN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.32, CTRN perfoms like the industry average, outperforming 46.40% of the companies in the same industry.
CTRN has a Quick Ratio of 1.32. This is a bad value and indicates that CTRN is not financially healthy enough and could expect problems in meeting its short term obligations.
CTRN's Quick ratio of 0.56 is in line compared to the rest of the industry. CTRN outperforms 48.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
The earnings per share for CTRN have decreased strongly by -209.32% in the last year.
CTRN shows a decrease in Revenue. In the last year, the revenue decreased by -5.91%.
CTRN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.57% yearly.
EPS 1Y (TTM)-209.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.14%
Revenue 1Y (TTM)-5.91%
Revenue growth 3Y-1.53%
Revenue growth 5Y-0.57%
Sales Q2Q%2.71%
3.2 Future
The Earnings Per Share is expected to grow by 26.14% on average over the next years. This is a very strong growth
CTRN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.25% yearly.
EPS Next Y24.69%
EPS Next 2Y44.65%
EPS Next 3Y38.77%
EPS Next 5Y26.14%
Revenue Next Year1.54%
Revenue Next 2Y2.06%
Revenue Next 3Y3.19%
Revenue Next 5Y4.25%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CTRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTRN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
CTRN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CTRN is more expensive than 68.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 222.08 |
4.3 Compensation for Growth
CTRN's earnings are expected to grow with 38.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.65%
EPS Next 3Y38.77%
5. Dividend
5.1 Amount
CTRN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CITI TRENDS INC
NASDAQ:CTRN (5/31/2024, 7:00:00 PM)
After market: 24.43 0 (0%)24.43
+0.3 (+1.24%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap208.63M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.3% | ||
| ROE | -7.55% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 38.11% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-209.32%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y24.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-5.91%
Revenue growth 3Y-1.53%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y